Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants
Olivia Castellini-Pérez(Universidad de Granada), N. Ortego(Instituto de Investigación Biosanitaria de Granada), Martin Kerick(Max Planck Institute for Molecular Genetics), Michaela Lehner(Medical University of Vienna), Anne‐Lise Maudoux(UCLouvain), Divi Cornec(Uppsala University), Georg Stummvoll(Medical University of Vienna), Rik Lories(KU Leuven), Carlos Vasconcelos(Hospital de Santo António), Ana Campar(Centro Hospitalar do Porto), Concepción Marañón(Karolinska University Hospital), Alain Saraux(Centre Hospitalier Régional Universitaire de Brest), Esmeralda Neves(Universidade do Porto), Mariana Brandão(Centro Hospitalar do Porto), Ricard Cervera(Hospital Clínic de Barcelona), Guillermo Barturen(Universidad de Granada), Michael Zauner(Medical University of Vienna), N.T. Baerlecken(Medizinische Hochschule Hannover), Raúl López-Domínguez(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Nicolas Hunzelmann(University Hospital Cologne), R. Ortega Castro(Instituto Maimónides de Investigación Biomédica de Córdoba), Valérie Devauchelle‐Pensec(Autoimmune Technologies (United States)), Elena Povedano(Consejo Superior de Investigaciones Científicas), Eduardo Collantes‐Estévez(Hospital Universitario Reina Sofía), Ellen De Langhe(Universitair Ziekenhuis Leuven), António Marinho(Centro Hospitalar do Porto), Barbara Vigone(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Ignasi Rodríguez‐Pintó(Hospital Clínic de Barcelona), Sandrine Jousse‐Joulin(Inserm), Fátima Farinha(Centro Hospitalar do Porto), M. Á. Aguirre(Instituto Maimónides de Investigación Biomédica de Córdoba), Javier Martı́n(Instituto de Parasitología y Biomedicina "López - Neyra"), Raquel Faria(CUF Porto Hospital), Bernard Lauwerys(UCLouvain), Isabel Almeida(Centro Hospitalar do Porto), Manuel Martínez‐Bueno(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Esteban Ballestar(Institut d'Investigació Biomédica de Bellvitge), Lorenzo Beretta, Ricardo Blanco(Universidad de Cantabria), Jacques‐Olivier Pers(Université de Bretagne Occidentale), Alejandro Escudero‐Contreras(Instituto Maimónides de Investigación Biomédica de Córdoba), Julie Ducreux(UCLouvain), Gerard Espinosa(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Doreen Belz, Ana Tavares(Centro Hospitalar do Porto), Alfonso Corrales Martínez(Marqués de Valdecilla University Hospital), Andrii Iakovliev(University of Edinburgh), Ma Carmen Castro‐Villegas(Andalusian Health Service), Torsten Witte
Cited by 8
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726